Trademark: 90057531
Word
MINARIS
Status Date
Tuesday, August 23, 2022
Registration Number
6823488
Registration Date
Tuesday, August 23, 2022
Filing Date
Thursday, July 16, 2020
Published for Opposition
Tuesday, June 7, 2022
40 Contract manufacturing in the field of biological cells; contract manufacturing of cell tissue; contracted biological cell processing; information, advice and consultancy services relating to biological cell manufacturing; contract manufacturing in the field of biologics and pharmaceuticals; contracted cell culturing and tissue culturing in the nature of custom processing and manufacturing in the field of biological cells and tissues; advisory services in the field of cell culturing in the nature of advisory services in the field of custom processing and manufacturing in the field of biological cells; contract manufacturing of cell therapies, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration
44 Medical services, namely, contracted cell culturing and tissue culturing for medical purposes; medical advisory services, namely, advisory services in the field of contracted cell culturing and tissue culturing for medical purposes; medical services, namely, separation and cultivation of body tissues and cells for medical purposes; information, advice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; medical, medicinal and pharmaceutical consultancy; isolation, collection and preservation of blood components including cells or stem cells obtained from umbilical cord blood, bone marrow, placenta and other parts of the human body, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, and cells of human or animal origin
42 Pharmaceutical research and development services, namely, contracted cell culturing and tissue culturing for scientific purposes; scientific and technological services, namely, testing, inspection for quality control purposes, and research in the field of cell culture and tissue culture, and consultancy and information services relating thereto; pharmaceutical research and development advisory services, namely, advisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue culture, and consultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of pharmaceuticals and biotechnology, and advisory services relating thereto; contracted development of biological cell manufacturing process; scientific laboratory services, namely, the cultivation or modification of hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration into living drugs.; quality control services in the field of cell culture and tissue culture, and consultancy relating thereto; quality control of cell and living tissue for others
The mark consists of two slightly overlapping hexagons, one blue and one green, each surrounded by a curved half circle, one blue and one green and the stylized wording "MINARIS" in blue.
The color(s) green and blue is/are claimed as a feature of the mark.
May 3, 2023
Automatic Update Of Assignment Of Ownership
Aug 23, 2022
Notice Of Registration Confirmation Emailed
Aug 23, 2022
Registered-Principal Register
Jun 7, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 7, 2022
Published For Opposition
May 18, 2022
Notification Of Notice Of Publication E-Mailed
Apr 29, 2022
Electronic Record Review Complete
Apr 1, 2022
On Hold - Electronic Record Review Required
Mar 31, 2022
Approved For Pub - Principal Register
Mar 3, 2022
Teas/Email Correspondence Entered
Mar 3, 2022
Correspondence Received In Law Office
Mar 2, 2022
Assigned To Lie
Feb 28, 2022
Teas Response To Suspension Inquiry Received
Oct 14, 2021
Notification Of Inquiry As To Suspension E-Mailed
Oct 14, 2021
Inquiry To Suspension E-Mailed
Oct 14, 2021
Suspension Inquiry Written
Sep 17, 2021
Suspension Checked ¿ To Attorney For Action
Feb 18, 2021
Notification Of Letter Of Suspension E-Mailed
Feb 18, 2021
Letter Of Suspension E-Mailed
Feb 18, 2021
Suspension Letter Written
Jan 26, 2021
Teas/Email Correspondence Entered
Jan 25, 2021
Correspondence Received In Law Office
Jan 25, 2021
Teas Response To Office Action Received
Jan 6, 2021
Automatic Update Of Assignment Of Ownership
Oct 6, 2020
Notification Of Non-Final Action E-Mailed
Oct 6, 2020
Non-Final Action E-Mailed
Oct 6, 2020
Non-Final Action Written
Oct 6, 2020
Assigned To Examiner
Aug 14, 2020
Notice Of Design Search Code E-Mailed
Aug 13, 2020
New Application Office Supplied Data Entered
Jul 20, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
